QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

TRVI

QT76Trevi Therapeutics, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
17.21
+0.84+5.13%
OverviewShort InterestFilings
TRVIQT76Trevi Therapeutics, Inc.·NASDAQ
OverviewShort InterestFilings
17.21+5.13%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-
Insider Own-
Shs Outstand141.98M
Perf Week27.86%
Market Cap2.32BForward P/E-EPS next Y-0.59Insider Trans0.00%Shs Float-Perf Month29.98%
Enterprise Value2.31BPEG-EPS next Q-0.11Inst Own-Short Float-Perf Quarter60.84%
Income-44468571.00P/S0.00EPS this Y-Inst Trans-Short Ratio-Perf Half Y38.68%
Sales-P/B13.87EPS next Y-25.23%ROA-25.39%Short Interest-Perf YTD37.46%
Book/sh1.34P/C-EPS next 5Y-ROE-24.53%52W High17.61 -2.27%Perf Year181.21%
Cash/sh1.37P/FCF-EPS past 3/5Y-ROIC-30.49%52W Low5.41 218.11%Perf 3Y-
Dividend Est.-EV/EBITDA-50.71Sales past 3/5Y-Gross Margin0.00%Volatility4.97% 3.41%Perf 5Y-
Dividend TTM-EV/Sales0.00EPS Y/Y TTM31.91%Oper. Margin0.00%ATR (14)0.82Perf 10Y-
Dividend Ex-Date-Quick Ratio24.75Sales Y/Y TTM-Profit Margin0.00%RSI (14)75.45Recom2.00
Dividend Gr. 3/5Y-Current Ratio24.75EPS Q/Q0.00%SMA2020.49%Beta1.14Target Price25.00
Payout0.00%Debt/Eq0.00Sales Q/Q-SMA5020.66%Rel Volume1.91Prev Close16.37
Employees31LT Debt/Eq0.01EarningsAug 06SMA20045.56%Avg Volume1.55MPrice17.21
IPO DateMay 07, 2019Option/ShortYes / YesEPS/Sales Surpr.-28.57% -Net Debt/EBITDA0.41Volume2,959,705Change5.13%
Analyst Ratings
DateActionAnalystRatingTarget
May-08-26ReiteratedStifel NicolausBuy$18 → $30
May-06-26ReiteratedMorgan StanleyOverweight$18 → $20
Dec-19-25ReiteratedStifel NicolausBuy$15 → $18
Nov-14-25ReiteratedMorgan StanleyOverweight$19
Nov-14-25ReiteratedOppenheimerOutperform$12 → $24
Mar-10-25UpgradeRaymond JamesOutperform → Strong Buy
Oct-22-24ReiteratedH.C. Wainwright$6.00
Oct-04-24ReiteratedB.Riley Financial$6.00
Jul-09-22ReiteratedOppenheimerOutperform$12
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
FY 2017
12/31/2017
Total Revenue
000
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A
000
Gross Profit
000
Selling, General and Administrative Excl. Other161210
Research and Development333924
Other Operating Expense010
Operating Income-49-52-34
Interest Expense000
Unusual Expense
———
Non-Operating Income (Expense)-7-4-5
Net Income Before Taxes-43-48-29
Income Taxes
000
Consolidated Net Income-43-48-29
Net Income From Continuing Operations-43-48-29
Net Income-43-48-29
EPS (Recurring)-0.29-0.47-0.29
EPS (Basic, Before Extraordinaries)-0.29-0.47-0.29
EPS (Diluted)-0.29-0.47-0.29
EBITDA-43-48-29
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
———
Gross Margin
———
Operating Margin
———
Net Margin
———
Shares Outstanding14510199
Market Capitalization1,815——
Operating Lease Expense
———
Insider Trading Volume
$20.72$18.55$16.38$14.22$12.05● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
SANDELL SCOTT D10% OwnerApr 17 '25Option Exercise1.371,851,8522,537,0370Feb 13 12:00 AM
Behbahani Ali10% OwnerApr 17 '25Option Exercise1.371,851,8522,537,0370Feb 13 12:00 AM
BASKETT FOREST10% OwnerApr 17 '25Option Exercise1.371,851,8522,537,0370Feb 13 12:00 AM
Makhzoumi Mohamad10% OwnerApr 17 '25Option Exercise1.371,851,8522,537,0370Feb 13 12:00 AM
Walker Paul Edward10% OwnerApr 17 '25Option Exercise1.371,851,8522,537,0370Feb 13 12:00 AM
New Enterprise Associates 16, L.P.10% OwnerApr 17 '25Option Exercise1.371,851,8522,537,0370Feb 13 12:00 AM
Chang Carmen10% OwnerApr 17 '25Option Exercise1.371,851,8522,537,0370Feb 13 12:00 AM
Florence Anthony A. Jr.10% OwnerApr 17 '25Option Exercise1.371,851,8522,537,0370Feb 13 12:00 AM
Galletta ChristopherSee RemarksDec 02 '25Option Exercise0.518,4504,31826,095Dec 03 12:00 AM
SCIASCIA THOMASChief Scientific OfficerMar 25 '25Option Exercise1.435,2627,524224,004Mar 26 12:00 AM
SCIASCIA THOMASChief Scientific OfficerMar 25 '25Sale6.602,63117,365221,373Mar 26 12:00 AM
GOOD JENNIFER LPresident & CEOMar 21 '25Option Exercise1.4310,52615,052218,576Mar 25 12:00 AM
GOOD JENNIFER LPresident & CEOMar 21 '25Sale6.585,26334,625213,313Mar 25 12:00 AM
Simon FarrellChief Commercial OfficerMar 10 '25Option Exercise2.86225,126643,306158,213Mar 12 12:00 AM
Simon FarrellChief Commercial OfficerMar 10 '25Sale6.7581,313548,87876,900Mar 12 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR